 |
answer text |
<p>No assessment has been made. Licensed cannabis-based medicines are routinely available
on the National Health Service, however, clinical guidelines from the National Institute
for Health and Care Excellence demonstrate a clear need for more evidence to support
routine prescribing and funding decisions for unlicensed cannabis based products for
medicinal use in humans. Until that evidence base is built, prescribers will remain
reticent to prescribe and no decision can be made by the NHS on routine funding.</p><p>We
continue to call on manufacturers to conduct research and we are working with regulatory,
research and NHS partners to establish clinical trials to test the safety and efficacy
of these products.</p>
|
 |
